ALBEMARLE CORP (ALB) Forecast, Price Target & Analyst Ratings
NYSE:ALB • US0126531013
165.42 USD
-1.12 (-0.67%)
Last: Mar 11, 2026, 11:46 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALBEMARLE CORP (ALB).
Forecast Snapshot
Consensus Price Target
$190.59
+ 15.22% Upside
Next Earnings Forecast
Release DateApr 28, 2026
PeriodQ1 / 2026
EPS Estimate$0.90
Revenue Estimate1.302B
ChartMill Buy Consensus
76.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$190.59
Upside
+ 15.22%
From current price of $165.42 to mean target of $190.59, Based on 30 analyst forecasts
Low
$84.11
Median
$200.59
High
$241.50
Price Target Revisions
1 Month
11.28%
3 Months
74.53%
Price Target Summary
30 Wall Street analysts provided a forecast for the next 12 months for ALB. The average price target is 190.59 USD. This implies a price increase of 15.22% is expected in the next year compared to the current price of 165.42.
The average price target has been revised upward by 74.53% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
76.67%
ALB was analyzed by 30 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ALB.
In the previous month the buy percentage consensus was at a similar level.
ALB was analyzed by 30 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-18 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-17 | B of A Securities | Upgrade | Neutral -> Buy |
| 2026-02-13 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-28 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-01-28 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-01-21 | Truist Securities | Upgrade | Hold -> Buy |
| 2026-01-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-13 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2026-01-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-12 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2026-01-12 | UBS | Maintains | Buy -> Buy |
| 2026-01-07 | Baird | Upgrade | Neutral -> Outperform |
| 2026-01-06 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-19 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-18 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-12-18 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-05 | UBS | Upgrade | Neutral -> Buy |
| 2025-12-03 | Deutsche Bank | Maintains | Hold -> Hold |
| 2025-12-02 | Baird | Upgrade | Underperform -> Neutral |
| 2025-11-19 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-11-13 | Mizuho | Maintains | Neutral -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 28, 2026
PeriodQ1 / 2026
EPS Estimate$0.90
Revenue Estimate1.302B
Revenue Q2Q20.90%
EPS Q2Q598.10%
Number of Analysts19
Next Earnings Revisions
Revenue (1 Month)
5.77%
Revenue (3 Months)
17.40%
EPS (1 Month)
4,633.76%
EPS (3 Months)
335.94%
Next Earnings Summary
ALB is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is 0.9 USD and the consensus revenue estimate is 1.30B USD.
The next earnings revenue estimate has been revised upward by 17.4% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.617B 31.38% | 5.378B -44.08% | 5.143B -4.37% | 5.675B 10.35% | 6.026B 6.19% | 6.52B 8.20% | 7.936B 21.72% | 8.766B 10.46% | 9.962B 13.64% | 10.351B 3.90% | 8.653B -16.40% | |
| EBITDA YoY % growth | 889.2M -68.28% | -40.668M -104.57% | 741.466M 1,923.22% | 2.145B 189.29% | 2.389B 11.38% | 2.583B 8.12% | 4.453B 72.40% | 4.69B 5.32% | 5.518B 17.65% | 5.749B 4.19% | 3.933B -31.59% | |
| EBIT YoY % growth | 459.256M -81.65% | -629.306M -237.03% | 82.788M 113.16% | 743.61M 798.21% | 1.132B 52.23% | 1.442B 27.39% | 1.798B 24.69% | 2.351B 30.76% | N/A | N/A | N/A | |
| Operating Margin | 4.78% | -11.70% | 1.61% | 13.10% | 18.79% | 22.12% | 22.66% | 26.82% | N/A | N/A | N/A | |
| EPS YoY % growth | 22.24 1.32% | -2.34 -110.52% | -0.79 66.24% | 7.52 1,051.57% | 8.83 17.53% | 10.71 21.28% | 17.26 61.10% | 20.19 16.97% | 31.28 54.93% | 31.98 2.23% | 20.75 -35.12% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.90 598.10% | 1.94 1,665.32% | 0.78 513.04% | 0.57 207.08% | 0.99 9.89% | 2.10 8.21% | 2.40 205.34% | 2.40 322.69% |
| Revenue Q2Q % growth | 1.302B 20.90% | 1.402B 5.41% | 1.415B 8.19% | 1.409B -1.33% | 1.401B 7.60% | 1.762B 25.68% | 2.054B 45.16% | 2.098B 48.90% |
| EBITDA Q2Q % growth | 420.17M 134.35% | 571.71M 51.35% | 397.94M -14.61% | 356.68M -48.42% | 484.53M 15.32% | 633.02M 10.72% | 705.7M 77.34% | 707.78M 98.44% |
| EBIT Q2Q % growth | 92.711M 428.63% | 186.62M 295.02% | 143.59M 595.86% | 104.26M 217.24% | 253.59M 173.53% | 404.67M 116.84% | 397.74M 177.00% | 461.65M 342.79% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
149.67%
EPS Next 5 Year
94.11%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
8.48%
Revenue Next 5 Year
11.41%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
201.65%
EBIT Next 5 Year
117.08%
ALBEMARLE CORP / ALB Forecast FAQ
What is the average price target for ALBEMARLE CORP (ALB) stock?
30 analysts have analysed ALB and the average price target is 190.59 USD. This implies a price increase of 15.22% is expected in the next year compared to the current price of 165.42.
When does ALBEMARLE CORP (ALB) report earnings?
ALBEMARLE CORP (ALB) will report earnings on 2026-04-28, after the market close.
What are the consensus estimates for ALB stock next earnings?
The consensus EPS estimate for the next earnings of ALBEMARLE CORP (ALB) is 0.9 USD and the consensus revenue estimate is 1.30B USD.
What is the expected long term growth rate for ALB stock?
The expected long term growth rate for ALBEMARLE CORP (ALB) is 8.48%.